Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LIQUIZYME SINGLE SOLUTION GLUCOSE REAG

K-Number: K811592 · 1981-07-01

ApplicantAmresco, Inc.
Decision Date1981-07-01
Product CodeCGA
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

LIQUIZYME SINGLE SOLUTION GLUCOSE REAG is the device name listed in this FDA 510(k) record. The listed applicant is Amresco, Inc.. It received FDA 510(k) clearance on 1981-07-01 under 510(k) number K811592. The device is classified under product code CGA. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LIQUIZYME SINGLE SOLUTION GLUCOSE REAG?

LIQUIZYME SINGLE SOLUTION GLUCOSE REAG is a medical device that received FDA 510(k) clearance on 1981-07-01. The listed applicant is Amresco, Inc.. The 510(k) number is K811592.

When did LIQUIZYME SINGLE SOLUTION GLUCOSE REAG receive FDA 510(k) clearance?

LIQUIZYME SINGLE SOLUTION GLUCOSE REAG received FDA 510(k) clearance on 1981-07-01, under 510(k) number K811592.

Who is the listed applicant for LIQUIZYME SINGLE SOLUTION GLUCOSE REAG?

The FDA 510(k) record lists Amresco, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for LIQUIZYME SINGLE SOLUTION GLUCOSE REAG?

The FDA product code for LIQUIZYME SINGLE SOLUTION GLUCOSE REAG is CGA.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Amresco, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K905618GGT REAGENTK904468DIRECT BILIRUBIN REAGENT, 7776/7777/7576/7476/7176K905684ALKALINE PHOSPHATASEK905544MAGNESIUM REAGENTK905284HDL-CHOLESTEROL PRECIPITANT 7773/7573/7473/7173K904004AMRESCOCREAT KINASE REAGENT 7716/17,7516,7416,7116

View all 39 devices →

Related Devices (Code: CGA)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K252488ABL90 FLEX PLUS SystemRadiometer Medicals ApsK210933YSI 2900C Biochemistry AnalyzerYsi, Inc.K220328EasyStat 300Medica CorporationK223179Cholestech LDX ™ SystemAlere San Diego, Inc.K223755i-STAT G cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.K223710i-STAT CG8+ cartridge with the i-STAT 1 SystemAbbott Point of Care, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑